Article
High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway.
Molecular cancer therapeutics - 1 May 2012
Levallet Guénaëlle, Bergot Emmanuel, Antoine Martine, Creveuil Christian, Santos Adriana O, Beau-Faller Michelle, de Fraipont Florence, Brambilla Elisabeth, Levallet Jérôme, Morin Franck, Westeel Virginie, Wislez Marie, Quoix Elisabeth, Debieuvre Didier, Dubois Fatéméh, Rouquette Isabelle, Pujol Jean-Louis, Moro-Sibilot Denis, Camonis Jacques, Zalcman Gérard
Abstract excerpt
We assessed the prognostic and predictive value of β-tubulin III (TUBB3) expression, as determined by immunohistochemistry, in 412 non-small cell lung cancer (NSCLC) specimens from early-stage patients who received neoadjuvant chemotherapy (paclitaxel- or gemcitabine-based) in a phase III trial (IFCT-0002). We also correlated TUBB3 expression with K-Ras and EGF receptor (EGFR) mutations in a subset of 208...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
